{"ticker": {"uuid": "486ab989-f120-4769-ae89-ae0116149e46", "symbol": "BSX", "name": "Boston Scientific Corp", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Goldman Sachs Keeps Their Buy Rating on Boston Scientific (BSX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxOdkRYZmRQWkhGN0pTeEo5c0k2aV8tVENZWWRIczUzeklmYzRDLWtOY19qMTVHMW9sbEtzeXhzT3ZTRV83TDc4TmxfSjRoZHRyNHI3UHlqNGhpdml4ekg5NElfak55d240dTZaUktSNkVEYU90NndVa1BjTjlMYXZINk9LYmR1RFVNNFVLUkd4a05fRjBvNmNfeGVKSjFaZ1ZicF96NTZDakE3VzBRTHRmbmo1UWVHZ2I4V2kteVNhUndab3ZzY1NsTnVvd1B5MXlKXzRJZmVRNGlnZw?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-16T20:51:10+00:00", "published_display": "16 Jul 2026 20:51", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains", "summary": "Boston Scientific Corp. (BSX) shares rose by 3.67% on Thursday, closing at $44.62, even as the broader market saw declines with the S&P 500 and Dow Jones Industrial Average falling. Despite its daily gains, the stock underperformed compared to its competitors. This marks the seco", "url": "https://www.marketwatch.com/data-news/boston-scientific-corp-stock-underperforms-thursday-when-compared-to-competitors-despite-daily-gains-ec481b19-c352a76bedb5?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-16T21:07:21", "published_display": "16 Jul 2026 21:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist Adjusts Price Target on Boston Scientific to $62 From $64, Maintains Buy Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/truist-adjusts-price-target-boston-131024615.html", "source_name": "MT Newswires", "published_at": "2026-07-16T13:10:24+00:00", "published_display": "16 Jul 2026 13:10", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific Expands Medical Device R&D in Ireland With \u20ac75 Million Investment", "summary": "Boston Scientific is investing \u20ac75 million to expand its research and development capabilities at its Galway facility in Ireland. This investment will enhance the site's role in developing next-generation cardiovascular and medical technologies, including new laboratories. The ex", "url": "https://www.assemblymag.com/articles/100220-boston-scientific-expands-medical-device-r-and-d-in-ireland-with-75-million-investment", "source_name": "Assembly Magazine", "published_at": "2026-07-16T11:00:21", "published_display": "16 Jul 2026 11:00", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mizuho Adjusts Price Target on Boston Scientific to $70 From $90, Maintains Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/mizuho-adjusts-price-target-boston-152431773.html", "source_name": "MT Newswires", "published_at": "2026-07-15T15:24:31+00:00", "published_display": "15 Jul 2026 15:24", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific stock hits 52-week low at 42.24 USD By Investing.com", "summary": "Boston Scientific's stock has plunged to a 52-week low of $42.24, marking a greater than 60% decline from its peak, despite the company's \"GREAT\" financial health and 17% revenue growth. This downturn, influenced by anticipated flat sales for its WATCHMAN device, has led several ", "url": "https://za.investing.com/news/stock-market-news/boston-scientific-stock-hits-52week-low-at-4224-usd-93CH-4370528", "source_name": "Investing.com South Africa", "published_at": "2026-07-15T14:37:16", "published_display": "15 Jul 2026 14:37", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific stock hits 52-week low at 42.24 USD", "summary": "Boston Scientific's stock has fallen to a 52-week low of $42.24, significantly below its high of $109.50. Despite analysts maintaining \"Buy\" ratings, several firms have lowered price targets due to anticipated slowdowns in WATCHMAN device sales. The company currently has a \"GREAT", "url": "https://m.uk.investing.com/news/stock-market-news/boston-scientific-stock-hits-52week-low-at-4224-usd-93CH-4772173?ampMode=1", "source_name": "Investing.com", "published_at": "2026-07-15T14:07:23", "published_display": "15 Jul 2026 14:07", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific (BSX) Faces WATCHMAN Slowdown But Analysts Still See Upside", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/boston-scientific-bsx-faces-watchman-092116114.html", "source_name": "Insider Monkey", "published_at": "2026-07-15T09:21:16+00:00", "published_display": "15 Jul 2026 09:21", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Boston Scientific (BSX)", "summary": "RBC Capital maintained a Buy rating on Tandem Diabetes Care (TNDM) with a price target of $30.00. TD Cowen maintained a Buy rating on Boston Scientific (BSX) with a price target of $61.00, while the general analyst consensus for Boston Scientific is a Strong Buy with a $71.20 ave", "url": "https://www.theglobeandmail.com/investing/markets/stocks/BSX/pressreleases/3288349/analysts-offer-insights-on-healthcare-companies-tandem-diabetes-care-tndm-and-boston-scientific-bsx/", "source_name": "The Globe and Mail", "published_at": "2026-07-15T06:13:15", "published_display": "15 Jul 2026 06:13", "sentiment": "positive", "sentiment_pct": 74, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific (BSX) Stock Looks Cheap On Earnings While Returns Stay Weak", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-15T04:10:33+00:00", "published_display": "15 Jul 2026 04:10", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Boston Scientific\u2019s (BSX) Sterile-Packaging Recalls Reframing the Narrative on Quality and Regulatory Risk?", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/boston-scientific-bsx-sterile-packaging-011216919.html", "source_name": "Simply Wall St.", "published_at": "2026-07-15T01:12:16+00:00", "published_display": "15 Jul 2026 01:12", "sentiment": "negative", "sentiment_pct": 42, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Boston Scientific Corp. stock underperforms Tuesday when compared to competitors", "summary": "Boston Scientific Corp. (BSX) stock fell 4.52% to $42.63 on Tuesday, underperforming the broader market. This marked the third consecutive day of losses for the company's shares. The S&P 500 Index and the Dow Jones Industrial Average both saw gains on the same trading day.", "url": "https://www.marketwatch.com/data-news/boston-scientific-corp-stock-underperforms-tuesday-when-compared-to-competitors-02467a35-d7291dd0dc97?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-14T16:45:00", "published_display": "14 Jul 2026 16:45", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird Cuts Price Target on Boston Scientific to $64 From $70, Maintains Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/baird-cuts-price-target-boston-110019042.html", "source_name": "MT Newswires", "published_at": "2026-07-14T11:00:19+00:00", "published_display": "14 Jul 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific (BSX): Buy, Sell, or Hold Post Q1 Earnings?", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNTFlBZDlvdldnTWthd01XVE9WMy15c3huWWFDQVNlNjlId2VGWE15RjNjRzNMcDBZX0JiODBobUlybVIydktFakJPZGVuYWxTVGZDZzJLMzQxMnFiaDJGb0hNdUJ6a1pva05rcjRCYldwcWYxXzVSaW84ajNQRjBsM1dzcTc5dUotSVluMWtfdXNfajJBWVNqbS03V0kzNklfWnZLRW5sSDdoWkZ1c2pVdkFGZkM?oc=5", "source_name": "StockStory", "published_at": "2026-07-14T07:00:00+00:00", "published_display": "14 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific stock reflects steady medtech demand", "summary": "Boston Scientific's stock mirrors the long-term growth in minimally invasive medical devices, driven by its diversified portfolio across various interventional therapies. The company benefits from structural demand factors like aging populations and technological advancements lea", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/boston-scientific-stock-reflects-steady-medtech-demand/69762743", "source_name": "Ad Hoc News", "published_at": "2026-07-14T00:41:18", "published_display": "14 Jul 2026 00:41", "sentiment": "positive", "sentiment_pct": 76, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific stock reflects steady growth outlook as medical device demand expands", "summary": "Boston Scientific (BSX) is positioned as a leading S&P 500 medical device company, specializing in minimally invasive therapies across cardiology, endoscopy, and neuromodulation. The company's investment appeal stems from its diversified product portfolio, global scale, and focus", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/boston-scientific-stock-reflects-steady-growth-outlook-as-medical-device/69759636", "source_name": "Ad Hoc News", "published_at": "2026-07-13T10:37:21", "published_display": "13 Jul 2026 10:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific Corporation (BSX) Is A Stock To Buy According To D. E. Shaw", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQTVNmbFFnMkNfYWJGcWg5dk41cDdtelBCQl9nRzRjWjhfankzM3M3V3doMFA1QmpkOUhvUXctZC1zM3JfeUluVEo0QUVWaFdhUU5UdTdjeEdQZXc3ZkJwT2V1ZXlKd3RxajR4cjc0cjRjMXhidThLN0prQkg3UGJRZ3ZkTUdpaGNxUW91RkRxbjJVRzB4eHh3OXNfMDJvY2JiZkF1eVc5Zw?oc=5", "source_name": "Market source", "published_at": "2026-07-12T14:04:24+00:00", "published_display": "12 Jul 2026 14:04", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BN stock holds steady as Boston Scientific grows its medtech base", "summary": "Boston Scientific Corp. (BN) is a large-cap medical device company listed on the NYSE, known for its diversified portfolio in cardiovascular, rhythm management, and interventional technologies. The company's revenue is driven by procedure volumes, product adoption, and innovation", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/bn-stock-holds-steady-as-boston-scientific-grows-its-medtech-base/69739055", "source_name": "Ad Hoc News", "published_at": "2026-07-10T17:21:11", "published_display": "10 Jul 2026 17:21", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQaHJaVk9qTUthaTdKLUM5YWFKMnRPWlN5eVNhVWMyZlVzZFR3emFVeXNpOFMwTzNNQzR2RkVqSmJvV09mOGtweWpRNDZ2WjVOTHBGMi1HV01LeEFUb3lKcGNYNDhMWEo5RDVqRERhdGY4eklaTVNkRG5WSlZfMWhsaWFFUHlFd1drcldjSjRfbk1meUg4ZjU2UzA1clRuZw?oc=5", "source_name": "Market source", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific: The Time Has Come To Catch This Falling Knife (NYSE:BSX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNeG1rUGJ5VHh3ajNhOWlsYnE0MVJ0RVRKRHBYdlp6cWlFa3ZiZC1sWXNROFFhdXl6WWxfQ2pmcjZuS3RFY0RlWmNmbTZUU2ZMV3piUXY2cEwzcGpWenFsOTJfSDk3Q0FPYm5iY1FHSjltMzR5dFhwaHFDZV9HMjFRdEFBWEM1MkNzY3hoMkdmSTNTaUdkMHBlOHh5T2haR0F2c2c?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific (BSX) Stock Could Be A Bargain After A 57% Slump", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQRHlnOHpETVZpcHU1ZWphdFFXaWo3OXJlak1EbERMcTNvVE92LUVweGd2Yml2T1VkbmdvTjFIOHZUamFuSlJ4Z1d0NDhEYklUZ2R3NzFGd2RGaG5pQWJlMnV2V0hScmR5bkhyN1BpZTlKNGFENHBJZ05YM2lfc05fU01rT2FKcmY1cEtfNE1GX1lTQXRfVHpQSWRZNkhmbmc?oc=5", "source_name": "Market source", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific\u2019s Quarterly Earnings Preview: What You Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPNEstblpBbmFqbmVwbjFmRzk1enlfTVMycnVpQWZ1MU4tRFRWMThDYzBzbHdNWVdmakVHUjM0RkdFNFF0Qnd6elRHLXZZaWdXOUpuUGZ4aDA0dHUtS001U3lucVl0NUNPd1UxMGVzNVVjbTRyQnRDRWVQVjJ3TWozQWFoSkkzUjdkVWxKVXhMR3ZFWUdTOXFyVU85YWNFcl9jWG1XaUpLYWU?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNOEp2SHRpY1kzV21PMTQ1UWc2M3VpOXhjNUZGYmo1cXphWWdRM3l6RzZBOUJYOTlsRXZRQjc0aUFGc1BrNGtEaFpJWEdhaFJYWmY5bWNWaklXb290NUEwYkM1NEdWZzFxdE5CeDF2X3RhS0ZHTzRvSzBIem9kYWtWd01Kd0h2dGVMRDVXM3VhUU9KQlBqdTJVakVJUDFfclE?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific (BSX) Faces Flat Watchman Revenue As Doctors Combine Heart Procedures", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How a Targeted Valve Recall and Watchman Questions at Boston Scientific (BSX) Have Changed Its Investment Story", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNUUJUNlFhSnBUczM3eTB3Z1dUaWwxVzE5SHl5VnR6N1VWdV9XQUNlY25VZzFlZ1ZMQ3hyNzBWUDRiRHZ2aVM1ZXdieEppcHBhMnpSVW1uVlFIVTBqSmlkVld0TlJNUHhxVWFiOVJQeTBkcjhGZDVyU2xxajhSakdFa19tRkk4UFgwTWp6LVV6cWlpVjVsR3NZbmdvR2FkY1Z3TkFZ?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Boston Scientific (BSX) Stock Moves -1.27%: What You Should Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNV3d3akdHUFRFSllYUGZsU1BnUlZPYmRJZGlka0xnREJuRWR2UnM1MUsxVFplUDRuWk03cVZsRzVzVW9JZlFnTVJFMGNsQzBOWlItU0ZKRHR6TWRvQW4zUC13RVBxeVV6aVREV3Y4LW5zRHhzeUs5TGdfU2g5LTZLMTQ3YWRQNHh1cWIwblltYWliSzk0c2pnUC1FLUNEd0k?oc=5", "source_name": "Market source", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RBC Capital reiterates Boston Scientific stock rating on Watchman outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOdENTdngxTW1EYW5BMzdtMVhyZnFPa0hnTlZrd0RZSENzdFlUTmtwdTlpRElrc1BmY1JaNTVMdXJCNmpQUXdfQnduOHJxa3QxZmNTMzA1aTJyWWpBd3V3YWlxSTFxZzg5SWdQQXRpWDRlV2syb0hmWFA2YTRpNnUtbmVsSHRzaEwyUHZfdTdnQmlIZ21KNWRCWUYxUDM0YXctM2tnVlVRSHFESk1tRUYzRHJ0OUZVZ3djYTloaVJxUmNjajI5YXU3YklXdWkzUQ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific stock hits 52-week low at $52.29", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPaDl1ZXRvLWJuOEVsN251V2F0cy1HcEx5Z0t4azhEN0FEMHVIV0ZZZ2dFTW13MVJTRWFIalBxZE9yLUpFMFBaVHJIMlFyQ0xQVEVnWm1sck83eHlMbmpJS3JQOGNnU2dVYmpxMGlMRWpSZXBKTDlySjBHQzdpcHFubUxiWXN1Z091VkFxcjJkSEhEVy14N21GWkhjT25OSURqNS1SaFptWQ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific shares fall 10% on Watchman weakness, competitive pressures", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxObzZXeEN6c3JiazNPWGFhb3lwU1o3TXlzSEZMcVlXeC1XUElCaGhQWTA4MnhZSGZjdDVUR0JzOTdhdHl0RkJ3dk04ZVdIaFpEQUx4bGY5RUdOcG5FRENTdVpsM1hwa2pNRHJzTUstc1dnQjNRdHFHcXMyWFppMHE4OVlfajNiUlNJWWZPcWMtazBYNVlybXpTTG9VSGxUYmk5ZUNVbUpQRHNfOGNkOGc?oc=5", "source_name": "Investing.com", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Cheryl Pegus buys Boston Scientific (BSX) shares in open-market trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPem5uUGZfZ1ZfM3dZZWx5ZlFxTVgta1hrTFRkZXA1bGxTQ2RQeDZON0w1YzFXTWtKcmdNWENfU1lkaHNPdVpnYUR3c01mU2tYdnRoQ0ZoOE5MZzF6bTBnbGZLNzdwZnFfNEJwNWhuUnR1Y1c2ZVh5ZkFKR3JjbEJiU2J0ZlNQYjVkZDEtWkFkYlRvS0ZZZm5nV0taUVEtUk0xTkpqd0Y3bE9Tby1zQjUyOFJWdGk1dw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Boston Scientific Pairs US$2b Buyback With MiRus TAVR Growth Bet", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNLXlJYVR5aU9mak1DbFR5ZV9XSi1YeTRRNmFEZWdQNzlQOFp0bk41WTJ5Y2hmWGZlYTUydUJmS2VXSGdKWnhrT3Z5MzZMM3FUZ3N2am53M3R4Q0pNaHEzZWpadlhESE9ndUhseGdYTXJmOGRyWmxlVXViRkdEY3p5ZkRqN1B3T1RVMzNfRHRtZGFlNHJNOHJCSXVn?oc=5", "source_name": "Market source", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific: A Rare 40% Drawdown Creates A Buying Opportunity (NYSE:BSX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNREx1ZEhzV1ZIc0ROcUJXZ01PTnFFVUV4TFQ3WUZtZ3FaYXNuS0ZhUzhEOWg4cTA0YmZFOXo2cW5ndGZtX3lOSEVqM09vNmRqa0JfNmt5TnpZcGZqVkhLc0VmeGxmQmNUcVhhUGlEcE5CZEpuQmpBWTJaeFlNY2oyZjhBTldJQVIzekxtNnFRZzlxb3JtZmlMR3p3U3QtZjAtbWJGdDB4V2ZaMFZLVWVzYlk4WWY?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SHAREHOLDER ALERT Securities Class Action Filed Against Boston Scientific Corporation (BSX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOVW0xR2RpNUVIanNzNXJ1R2RIeVJOSWlnQXZVcFhaUXc3dlVrSmhCem1EUF9jSmtzTEQzZVBBOTVLVkF0NVdyYVVHRHlwcWRQU3NsX0k2NVhOSTRSZy1sOGxmRXE0dDNaVEpyZklxdWl5cFRPVnQ4R00yYXJJZU1OQUJ3bHRscUpTSkZ4YzA2QzhCQXBOZC03RGdzWUhJa0NlOHRTRWtTeFpLNUtpd1RNSEtBWTVsX2xTNU5FU0VCZGpCZTZDQ1p0YmY2M1prdw?oc=5", "source_name": "TMX Newsfile", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Is It Time To Reconsider Boston Scientific (BSX) After Its Recent Share Price Slide?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Boston Scientific dives after disappointing clinical trial results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTE00VkpJTUh0S3VHTEM4cXNaNG5LdGR4TlZvdm4xWjFxMVpVcjRYUWpVTUxtTDFaUmtLcTExaFhranI0X0YtSk1oenZCenZxLWlmTEtScERjWWhBY0NxS2pKdzZLOA?oc=5", "source_name": "medwatch.com", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Reassessing Boston Scientific (BSX) After A 30% Pullback In The Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNU3drcVBHZmpvUVRUamI0WG01WTlzd1U1V2wwdHZwdzFfX3J1RGxUQWlNbTZHZGFwSjhNOXppMjU0aDc4N2RwUXZVcUNjTjB6SjI2b25mZkRya0VQNV82VEVaMklYdXF4am9GQVAxOG5yODRtdmR0THZ6a0tvemxPZk1xVlpNd1BUQUE?oc=5", "source_name": "Market source", "published_at": "2026-02-14T08:00:00+00:00", "published_display": "14 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific announces agreement to acquire Penumbra", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNUWg3ck5YN2pOYkpFcjZMWjc4VXFTek9od2RFTThIV3UtZHpNTllCTkYzckxWQWVhMzVBQ2xXSXRyVjZRZnlaLUtyZjV4MTlCRzhfRVI2V1R2LWx2NXJ1aVQyLUhId2dpR3AtaldlY3FoRXk2eko4djVsOGV6VGIwLW9ndW9uX2ky?oc=5", "source_name": "Venous News", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPdFlpVDdiVDlSSGlDUjlzdTNQcWJOaEtjcGR1STZqNzNqQzNoTktuVGVkaUNCNy10MDc1VnRQLXAwUERCWWRhRDJiLVQxdmJIbEo4ZVBZM1U5djRlcnRaVW5DLS1rVHEwcmNsdVp5RVF1TENOMjNXd3NiWEtfOFhDdmotdzI3OTBkNFd6c1ZNU0YyYW96MmJFZ1ZIc1JTdjE5WWUwWHJ2Vmhsc21WRjdHV3ZGcGQwVGFZRWN0M041dUdiUQ?oc=5", "source_name": "TradingView", "published_at": "2026-01-08T08:00:00+00:00", "published_display": "08 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Goldman Sachs Keeps Their Buy Rating on Boston Scientific (BSX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxOdkRYZmRQWkhGN0pTeEo5c0k2aV8tVENZWWRIczUzeklmYzRDLWtOY19qMTVHMW9sbEtzeXhzT3ZTRV83TDc4TmxfSjRoZHRyNHI3UHlqNGhpdml4ekg5NElfak55d240dTZaUktSNkVEYU90NndVa1BjTjlMYXZINk9LYmR1RFVNNFVLUkd4a05fRjBvNmNfeGVKSjFaZ1ZicF96NTZDakE3VzBRTHRmbmo1UWVHZ2I4V2kteVNhUndab3ZzY1NsTnVvd1B5MXlKXzRJZmVRNGlnZw?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-16T20:51:10+00:00", "published_display": "16 Jul 2026 20:51", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains", "summary": "Boston Scientific Corp. (BSX) shares rose by 3.67% on Thursday, closing at $44.62, even as the broader market saw declines with the S&P 500 and Dow Jones Industrial Average falling. Despite its daily gains, the stock underperformed compared to its competitors. This marks the seco", "url": "https://www.marketwatch.com/data-news/boston-scientific-corp-stock-underperforms-thursday-when-compared-to-competitors-despite-daily-gains-ec481b19-c352a76bedb5?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-16T21:07:21", "published_display": "16 Jul 2026 21:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist Adjusts Price Target on Boston Scientific to $62 From $64, Maintains Buy Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/truist-adjusts-price-target-boston-131024615.html", "source_name": "MT Newswires", "published_at": "2026-07-16T13:10:24+00:00", "published_display": "16 Jul 2026 13:10", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific Expands Medical Device R&D in Ireland With \u20ac75 Million Investment", "summary": "Boston Scientific is investing \u20ac75 million to expand its research and development capabilities at its Galway facility in Ireland. This investment will enhance the site's role in developing next-generation cardiovascular and medical technologies, including new laboratories. The ex", "url": "https://www.assemblymag.com/articles/100220-boston-scientific-expands-medical-device-r-and-d-in-ireland-with-75-million-investment", "source_name": "Assembly Magazine", "published_at": "2026-07-16T11:00:21", "published_display": "16 Jul 2026 11:00", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mizuho Adjusts Price Target on Boston Scientific to $70 From $90, Maintains Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/mizuho-adjusts-price-target-boston-152431773.html", "source_name": "MT Newswires", "published_at": "2026-07-15T15:24:31+00:00", "published_display": "15 Jul 2026 15:24", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific stock hits 52-week low at 42.24 USD By Investing.com", "summary": "Boston Scientific's stock has plunged to a 52-week low of $42.24, marking a greater than 60% decline from its peak, despite the company's \"GREAT\" financial health and 17% revenue growth. This downturn, influenced by anticipated flat sales for its WATCHMAN device, has led several ", "url": "https://za.investing.com/news/stock-market-news/boston-scientific-stock-hits-52week-low-at-4224-usd-93CH-4370528", "source_name": "Investing.com South Africa", "published_at": "2026-07-15T14:37:16", "published_display": "15 Jul 2026 14:37", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific stock hits 52-week low at 42.24 USD", "summary": "Boston Scientific's stock has fallen to a 52-week low of $42.24, significantly below its high of $109.50. Despite analysts maintaining \"Buy\" ratings, several firms have lowered price targets due to anticipated slowdowns in WATCHMAN device sales. The company currently has a \"GREAT", "url": "https://m.uk.investing.com/news/stock-market-news/boston-scientific-stock-hits-52week-low-at-4224-usd-93CH-4772173?ampMode=1", "source_name": "Investing.com", "published_at": "2026-07-15T14:07:23", "published_display": "15 Jul 2026 14:07", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific (BSX) Faces WATCHMAN Slowdown But Analysts Still See Upside", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/boston-scientific-bsx-faces-watchman-092116114.html", "source_name": "Insider Monkey", "published_at": "2026-07-15T09:21:16+00:00", "published_display": "15 Jul 2026 09:21", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Boston Scientific (BSX)", "summary": "RBC Capital maintained a Buy rating on Tandem Diabetes Care (TNDM) with a price target of $30.00. TD Cowen maintained a Buy rating on Boston Scientific (BSX) with a price target of $61.00, while the general analyst consensus for Boston Scientific is a Strong Buy with a $71.20 ave", "url": "https://www.theglobeandmail.com/investing/markets/stocks/BSX/pressreleases/3288349/analysts-offer-insights-on-healthcare-companies-tandem-diabetes-care-tndm-and-boston-scientific-bsx/", "source_name": "The Globe and Mail", "published_at": "2026-07-15T06:13:15", "published_display": "15 Jul 2026 06:13", "sentiment": "positive", "sentiment_pct": 74, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific (BSX) Stock Looks Cheap On Earnings While Returns Stay Weak", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-15T04:10:33+00:00", "published_display": "15 Jul 2026 04:10", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Boston Scientific\u2019s (BSX) Sterile-Packaging Recalls Reframing the Narrative on Quality and Regulatory Risk?", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/boston-scientific-bsx-sterile-packaging-011216919.html", "source_name": "Simply Wall St.", "published_at": "2026-07-15T01:12:16+00:00", "published_display": "15 Jul 2026 01:12", "sentiment": "negative", "sentiment_pct": 42, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific Corp. stock underperforms Tuesday when compared to competitors", "summary": "Boston Scientific Corp. (BSX) stock fell 4.52% to $42.63 on Tuesday, underperforming the broader market. This marked the third consecutive day of losses for the company's shares. The S&P 500 Index and the Dow Jones Industrial Average both saw gains on the same trading day.", "url": "https://www.marketwatch.com/data-news/boston-scientific-corp-stock-underperforms-tuesday-when-compared-to-competitors-02467a35-d7291dd0dc97?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-14T16:45:00", "published_display": "14 Jul 2026 16:45", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird Cuts Price Target on Boston Scientific to $64 From $70, Maintains Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/baird-cuts-price-target-boston-110019042.html", "source_name": "MT Newswires", "published_at": "2026-07-14T11:00:19+00:00", "published_display": "14 Jul 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific (BSX): Buy, Sell, or Hold Post Q1 Earnings?", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNTFlBZDlvdldnTWthd01XVE9WMy15c3huWWFDQVNlNjlId2VGWE15RjNjRzNMcDBZX0JiODBobUlybVIydktFakJPZGVuYWxTVGZDZzJLMzQxMnFiaDJGb0hNdUJ6a1pva05rcjRCYldwcWYxXzVSaW84ajNQRjBsM1dzcTc5dUotSVluMWtfdXNfajJBWVNqbS03V0kzNklfWnZLRW5sSDdoWkZ1c2pVdkFGZkM?oc=5", "source_name": "StockStory", "published_at": "2026-07-14T07:00:00+00:00", "published_display": "14 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific stock reflects steady medtech demand", "summary": "Boston Scientific's stock mirrors the long-term growth in minimally invasive medical devices, driven by its diversified portfolio across various interventional therapies. The company benefits from structural demand factors like aging populations and technological advancements lea", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/boston-scientific-stock-reflects-steady-medtech-demand/69762743", "source_name": "Ad Hoc News", "published_at": "2026-07-14T00:41:18", "published_display": "14 Jul 2026 00:41", "sentiment": "positive", "sentiment_pct": 76, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific stock reflects steady growth outlook as medical device demand expands", "summary": "Boston Scientific (BSX) is positioned as a leading S&P 500 medical device company, specializing in minimally invasive therapies across cardiology, endoscopy, and neuromodulation. The company's investment appeal stems from its diversified product portfolio, global scale, and focus", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/boston-scientific-stock-reflects-steady-growth-outlook-as-medical-device/69759636", "source_name": "Ad Hoc News", "published_at": "2026-07-13T10:37:21", "published_display": "13 Jul 2026 10:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific Corporation (BSX) Is A Stock To Buy According To D. E. Shaw", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQTVNmbFFnMkNfYWJGcWg5dk41cDdtelBCQl9nRzRjWjhfankzM3M3V3doMFA1QmpkOUhvUXctZC1zM3JfeUluVEo0QUVWaFdhUU5UdTdjeEdQZXc3ZkJwT2V1ZXlKd3RxajR4cjc0cjRjMXhidThLN0prQkg3UGJRZ3ZkTUdpaGNxUW91RkRxbjJVRzB4eHh3OXNfMDJvY2JiZkF1eVc5Zw?oc=5", "source_name": "Market source", "published_at": "2026-07-12T14:04:24+00:00", "published_display": "12 Jul 2026 14:04", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BN stock holds steady as Boston Scientific grows its medtech base", "summary": "Boston Scientific Corp. (BN) is a large-cap medical device company listed on the NYSE, known for its diversified portfolio in cardiovascular, rhythm management, and interventional technologies. The company's revenue is driven by procedure volumes, product adoption, and innovation", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/bn-stock-holds-steady-as-boston-scientific-grows-its-medtech-base/69739055", "source_name": "Ad Hoc News", "published_at": "2026-07-10T17:21:11", "published_display": "10 Jul 2026 17:21", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQaHJaVk9qTUthaTdKLUM5YWFKMnRPWlN5eVNhVWMyZlVzZFR3emFVeXNpOFMwTzNNQzR2RkVqSmJvV09mOGtweWpRNDZ2WjVOTHBGMi1HV01LeEFUb3lKcGNYNDhMWEo5RDVqRERhdGY4eklaTVNkRG5WSlZfMWhsaWFFUHlFd1drcldjSjRfbk1meUg4ZjU2UzA1clRuZw?oc=5", "source_name": "Market source", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific: The Time Has Come To Catch This Falling Knife (NYSE:BSX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNeG1rUGJ5VHh3ajNhOWlsYnE0MVJ0RVRKRHBYdlp6cWlFa3ZiZC1sWXNROFFhdXl6WWxfQ2pmcjZuS3RFY0RlWmNmbTZUU2ZMV3piUXY2cEwzcGpWenFsOTJfSDk3Q0FPYm5iY1FHSjltMzR5dFhwaHFDZV9HMjFRdEFBWEM1MkNzY3hoMkdmSTNTaUdkMHBlOHh5T2haR0F2c2c?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific (BSX) Stock Could Be A Bargain After A 57% Slump", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQRHlnOHpETVZpcHU1ZWphdFFXaWo3OXJlak1EbERMcTNvVE92LUVweGd2Yml2T1VkbmdvTjFIOHZUamFuSlJ4Z1d0NDhEYklUZ2R3NzFGd2RGaG5pQWJlMnV2V0hScmR5bkhyN1BpZTlKNGFENHBJZ05YM2lfc05fU01rT2FKcmY1cEtfNE1GX1lTQXRfVHpQSWRZNkhmbmc?oc=5", "source_name": "Market source", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific\u2019s Quarterly Earnings Preview: What You Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPNEstblpBbmFqbmVwbjFmRzk1enlfTVMycnVpQWZ1MU4tRFRWMThDYzBzbHdNWVdmakVHUjM0RkdFNFF0Qnd6elRHLXZZaWdXOUpuUGZ4aDA0dHUtS001U3lucVl0NUNPd1UxMGVzNVVjbTRyQnRDRWVQVjJ3TWozQWFoSkkzUjdkVWxKVXhMR3ZFWUdTOXFyVU85YWNFcl9jWG1XaUpLYWU?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNOEp2SHRpY1kzV21PMTQ1UWc2M3VpOXhjNUZGYmo1cXphWWdRM3l6RzZBOUJYOTlsRXZRQjc0aUFGc1BrNGtEaFpJWEdhaFJYWmY5bWNWaklXb290NUEwYkM1NEdWZzFxdE5CeDF2X3RhS0ZHTzRvSzBIem9kYWtWd01Kd0h2dGVMRDVXM3VhUU9KQlBqdTJVakVJUDFfclE?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific (BSX) Faces Flat Watchman Revenue As Doctors Combine Heart Procedures", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPR0NiZjI5NVM5a1VDNkVTZF9ZZ2JwQkM4ZDFPakhBWnptZUxGcUx3S21YRWFxTDZ3UFRNMWF6WnNMZllTY1R4dnV0bGxWdm5jeUxPUF9ENXRIVXJHWWtFODJxZDUxOWJvME1QWGRHSEQ3VmE0SkdUb0JnU0hRS0ZRQ0FEYk5DdUd5dzh3UGpqOG5pQzkxTm9ETTRrZnBIYWlEYzJHeWUxcFlqYjI1V0NFcVo4c0dfSWtDbG5YLWNJNDVZdldDT3duSExxcTZQZVNy0gHWAUFVX3lxTE93aVNfRm1ORUJMeGF5eEJFNUcwQUM0QkRrSTZBdDkxb1hNWERVb2tRNnVtS2gxaXcxN1FXU2x4WXk2bC15bWpWOUppNk5XSTJGbnI3LWZrZWNYZzBWdi1sRE5xN09FbFZpcThxYThXdHRjeFVJZXVPc2haWWtjam50UlNrdmpMTzA0b0JDcHRlVkxqT3VrNjlrMXhaYksyT3lTVDF5UWdWVFBMVjJ0Y0xJdDYxYVJVZ0w1QVBxU1VrNk4zUHBWWTk0MHFZZkM2UTA0d050Wnc?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How a Targeted Valve Recall and Watchman Questions at Boston Scientific (BSX) Have Changed Its Investment Story", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNUUJUNlFhSnBUczM3eTB3Z1dUaWwxVzE5SHl5VnR6N1VWdV9XQUNlY25VZzFlZ1ZMQ3hyNzBWUDRiRHZ2aVM1ZXdieEppcHBhMnpSVW1uVlFIVTBqSmlkVld0TlJNUHhxVWFiOVJQeTBkcjhGZDVyU2xxajhSakdFa19tRkk4UFgwTWp6LVV6cWlpVjVsR3NZbmdvR2FkY1Z3TkFZ?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific (BSX) Stock Moves -1.27%: What You Should Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNV3d3akdHUFRFSllYUGZsU1BnUlZPYmRJZGlka0xnREJuRWR2UnM1MUsxVFplUDRuWk03cVZsRzVzVW9JZlFnTVJFMGNsQzBOWlItU0ZKRHR6TWRvQW4zUC13RVBxeVV6aVREV3Y4LW5zRHhzeUs5TGdfU2g5LTZLMTQ3YWRQNHh1cWIwblltYWliSzk0c2pnUC1FLUNEd0k?oc=5", "source_name": "Market source", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RBC Capital reiterates Boston Scientific stock rating on Watchman outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOdENTdngxTW1EYW5BMzdtMVhyZnFPa0hnTlZrd0RZSENzdFlUTmtwdTlpRElrc1BmY1JaNTVMdXJCNmpQUXdfQnduOHJxa3QxZmNTMzA1aTJyWWpBd3V3YWlxSTFxZzg5SWdQQXRpWDRlV2syb0hmWFA2YTRpNnUtbmVsSHRzaEwyUHZfdTdnQmlIZ21KNWRCWUYxUDM0YXctM2tnVlVRSHFESk1tRUYzRHJ0OUZVZ3djYTloaVJxUmNjajI5YXU3YklXdWkzUQ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific stock hits 52-week low at $52.29", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPaDl1ZXRvLWJuOEVsN251V2F0cy1HcEx5Z0t4azhEN0FEMHVIV0ZZZ2dFTW13MVJTRWFIalBxZE9yLUpFMFBaVHJIMlFyQ0xQVEVnWm1sck83eHlMbmpJS3JQOGNnU2dVYmpxMGlMRWpSZXBKTDlySjBHQzdpcHFubUxiWXN1Z091VkFxcjJkSEhEVy14N21GWkhjT25OSURqNS1SaFptWQ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific shares fall 10% on Watchman weakness, competitive pressures", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxObzZXeEN6c3JiazNPWGFhb3lwU1o3TXlzSEZMcVlXeC1XUElCaGhQWTA4MnhZSGZjdDVUR0JzOTdhdHl0RkJ3dk04ZVdIaFpEQUx4bGY5RUdOcG5FRENTdVpsM1hwa2pNRHJzTUstc1dnQjNRdHFHcXMyWFppMHE4OVlfajNiUlNJWWZPcWMtazBYNVlybXpTTG9VSGxUYmk5ZUNVbUpQRHNfOGNkOGc?oc=5", "source_name": "Investing.com", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Cheryl Pegus buys Boston Scientific (BSX) shares in open-market trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPem5uUGZfZ1ZfM3dZZWx5ZlFxTVgta1hrTFRkZXA1bGxTQ2RQeDZON0w1YzFXTWtKcmdNWENfU1lkaHNPdVpnYUR3c01mU2tYdnRoQ0ZoOE5MZzF6bTBnbGZLNzdwZnFfNEJwNWhuUnR1Y1c2ZVh5ZkFKR3JjbEJiU2J0ZlNQYjVkZDEtWkFkYlRvS0ZZZm5nV0taUVEtUk0xTkpqd0Y3bE9Tby1zQjUyOFJWdGk1dw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific Pairs US$2b Buyback With MiRus TAVR Growth Bet", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNLXlJYVR5aU9mak1DbFR5ZV9XSi1YeTRRNmFEZWdQNzlQOFp0bk41WTJ5Y2hmWGZlYTUydUJmS2VXSGdKWnhrT3Z5MzZMM3FUZ3N2am53M3R4Q0pNaHEzZWpadlhESE9ndUhseGdYTXJmOGRyWmxlVXViRkdEY3p5ZkRqN1B3T1RVMzNfRHRtZGFlNHJNOHJCSXVn?oc=5", "source_name": "Market source", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific: A Rare 40% Drawdown Creates A Buying Opportunity (NYSE:BSX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNREx1ZEhzV1ZIc0ROcUJXZ01PTnFFVUV4TFQ3WUZtZ3FaYXNuS0ZhUzhEOWg4cTA0YmZFOXo2cW5ndGZtX3lOSEVqM09vNmRqa0JfNmt5TnpZcGZqVkhLc0VmeGxmQmNUcVhhUGlEcE5CZEpuQmpBWTJaeFlNY2oyZjhBTldJQVIzekxtNnFRZzlxb3JtZmlMR3p3U3QtZjAtbWJGdDB4V2ZaMFZLVWVzYlk4WWY?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SHAREHOLDER ALERT Securities Class Action Filed Against Boston Scientific Corporation (BSX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOVW0xR2RpNUVIanNzNXJ1R2RIeVJOSWlnQXZVcFhaUXc3dlVrSmhCem1EUF9jSmtzTEQzZVBBOTVLVkF0NVdyYVVHRHlwcWRQU3NsX0k2NVhOSTRSZy1sOGxmRXE0dDNaVEpyZklxdWl5cFRPVnQ4R00yYXJJZU1OQUJ3bHRscUpTSkZ4YzA2QzhCQXBOZC03RGdzWUhJa0NlOHRTRWtTeFpLNUtpd1RNSEtBWTVsX2xTNU5FU0VCZGpCZTZDQ1p0YmY2M1prdw?oc=5", "source_name": "TMX Newsfile", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reconsider Boston Scientific (BSX) After Its Recent Share Price Slide?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific dives after disappointing clinical trial results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTE00VkpJTUh0S3VHTEM4cXNaNG5LdGR4TlZvdm4xWjFxMVpVcjRYUWpVTUxtTDFaUmtLcTExaFhranI0X0YtSk1oenZCenZxLWlmTEtScERjWWhBY0NxS2pKdzZLOA?oc=5", "source_name": "medwatch.com", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reassessing Boston Scientific (BSX) After A 30% Pullback In The Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNU3drcVBHZmpvUVRUamI0WG01WTlzd1U1V2wwdHZwdzFfX3J1RGxUQWlNbTZHZGFwSjhNOXppMjU0aDc4N2RwUXZVcUNjTjB6SjI2b25mZkRya0VQNV82VEVaMklYdXF4am9GQVAxOG5yODRtdmR0THZ6a0tvemxPZk1xVlpNd1BUQUE?oc=5", "source_name": "Market source", "published_at": "2026-02-14T08:00:00+00:00", "published_display": "14 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Boston Scientific announces agreement to acquire Penumbra", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNUWg3ck5YN2pOYkpFcjZMWjc4VXFTek9od2RFTThIV3UtZHpNTllCTkYzckxWQWVhMzVBQ2xXSXRyVjZRZnlaLUtyZjV4MTlCRzhfRVI2V1R2LWx2NXJ1aVQyLUhId2dpR3AtaldlY3FoRXk2eko4djVsOGV6VGIwLW9ndW9uX2ky?oc=5", "source_name": "Venous News", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPdFlpVDdiVDlSSGlDUjlzdTNQcWJOaEtjcGR1STZqNzNqQzNoTktuVGVkaUNCNy10MDc1VnRQLXAwUERCWWRhRDJiLVQxdmJIbEo4ZVBZM1U5djRlcnRaVW5DLS1rVHEwcmNsdVp5RVF1TENOMjNXd3NiWEtfOFhDdmotdzI3OTBkNFd6c1ZNU0YyYW96MmJFZ1ZIc1JTdjE5WWUwWHJ2Vmhsc21WRjdHV3ZGcGQwVGFZRWN0M041dUdiUQ?oc=5", "source_name": "TradingView", "published_at": "2026-01-08T08:00:00+00:00", "published_display": "08 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 108, "total_relevant": 49, "sentiment_summary": {"positive": 12, "negative": 9, "neutral": 28, "score": 51, "total": 49, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 76, "events": [{"event": "general", "label": "Market update", "weight": 12.4, "count": 20}, {"event": "earnings", "label": "Earnings", "weight": 8.39, "count": 18}, {"event": "analyst", "label": "Analyst action", "weight": 2.75, "count": 5}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}], "positive_events": 12, "negative_events": 9}, "market_context": {"has_market_context": true, "latest_close": 44.77, "latest_week": "2026-07-10", "one_week_move": -0.8, "four_week_move": -4.6, "twelve_week_move": -30.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.787347, "market_dynamics_buy_signal": false, "relative_strength": -51.416331, "fair_value_gap": -43.3, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 45.7895, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.8% over one week, -4.6% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 48, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 18}, {"label": "Investing.com", "count": 4}, {"label": "MT Newswires", "count": 3}, {"label": "simplywall.st", "count": 3}, {"label": "StockStory", "count": 3}, {"label": "Ad Hoc News", "count": 3}, {"label": "The Globe and Mail", "count": 2}, {"label": "MarketWatch", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 38}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 20}, {"label": "Earnings", "count": 18}, {"label": "Analyst action", "count": 5}, {"label": "Regulatory and legal", "count": 2}, {"label": "Guidance", "count": 2}, {"label": "Macro sensitivity", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "76/100 classification confidence."}, {"label": "Company focus", "value": "38", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "4", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.8% over one week, -4.6% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Goldman Sachs Keeps Their Buy Rating on Boston Scientific (BSX)"}], "updated_at": "2026-07-17T03:18:39.729181+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}